Arcadia Biosciences (RKDA) Leases (2019 - 2025)
Arcadia Biosciences (RKDA) has disclosed Leases for 7 consecutive years, with $10000.0 as the latest value for Q2 2025.
- For the quarter ending Q2 2025, Leases fell 98.05% year-over-year to $10000.0, compared with a TTM value of $10000.0 through Jun 2025, down 98.05%, and an annual FY2024 reading of $137000.0, down 82.7% over the prior year.
- Leases was $10000.0 for Q2 2025 at Arcadia Biosciences, down from $19000.0 in the prior quarter.
- Across five years, Leases topped out at $6.4 million in Q2 2021 and bottomed at $10000.0 in Q2 2025.
- Average Leases over 5 years is $1.9 million, with a median of $1.5 million recorded in 2023.
- The sharpest move saw Leases increased 13.61% in 2021, then plummeted 98.05% in 2025.
- Year by year, Leases stood at $3.1 million in 2021, then crashed by 40.02% to $1.8 million in 2022, then plummeted by 57.14% to $792000.0 in 2023, then plummeted by 82.7% to $137000.0 in 2024, then plummeted by 92.7% to $10000.0 in 2025.
- Business Quant data shows Leases for RKDA at $10000.0 in Q2 2025, $19000.0 in Q1 2025, and $137000.0 in Q4 2024.